Key Takeaways
- • Dopl Technologies closed a $6.3 million seed funding round led by SpringTide Ventures, bringing total funding to more than $8 million since inception.
- • The Bothell, Washington-based medtech firm is developing a robotic ultrasound platform, addressing a potentially significant market gap in diagnostic imaging automation.
- • The funding syndicate includes 12+ investors spanning strategic, institutional, and community-focused categories, with co-investors including WRF Capital, Tacoma Venture Fund (pre-seed lead), HeartX, Transform Health Ventures, and Precursor Ventures.
- • The diversified investor base reflects confidence in the robotic ultrasound sector and signals strong regional venture activity in the Pacific Northwest medtech ecosystem.
Summary
Dopl Technologies, a medical technology company headquartered in Bothell, Washington, announced the close of a $6.3 million seed funding round led by SpringTide Ventures. The funding brings the company's total capitalization to more than $8 million, establishing a meaningful war chest for product development and market expansion in the robotic ultrasound space.
The company is developing a robotic ultrasound platform—a specialized application of automation in diagnostic imaging that addresses workflow inefficiencies and standardization challenges in clinical ultrasound procedures. This category of medtech innovation has attracted increasing institutional interest as healthcare systems seek to improve diagnostic consistency while managing labor constraints.
The seed round drew participation from a notably diverse investor syndicate comprising more than a dozen firms. Beyond lead investor SpringTide Ventures, the round included WRF Capital, Tacoma Venture Fund (which led Dopl's pre-seed round), HeartX, Transform Health Ventures, and Precursor Ventures, alongside additional early-stage institutional investors. The breadth of the investor base—spanning strategic corporate investors, institutional venture capital, and community-focused funds—suggests multi-stakeholder confidence in the company's technology trajectory and market potential.
The funding structure underscores activity in the Pacific Northwest's medtech venture ecosystem, with participation from regional players alongside nationally-recognized early-stage investors. For hedge funds and institutional investors tracking medtech innovation in automation and robotic systems, Dopl's capital raise represents a representative data point in the ongoing consolidation of venture capital around clinical automation and diagnostic workflow optimization.
The company is developing a robotic ultrasound platform—a specialized application of automation in diagnostic imaging that addresses workflow inefficiencies and standardization challenges in clinical ultrasound procedures. This category of medtech innovation has attracted increasing institutional interest as healthcare systems seek to improve diagnostic consistency while managing labor constraints.
The seed round drew participation from a notably diverse investor syndicate comprising more than a dozen firms. Beyond lead investor SpringTide Ventures, the round included WRF Capital, Tacoma Venture Fund (which led Dopl's pre-seed round), HeartX, Transform Health Ventures, and Precursor Ventures, alongside additional early-stage institutional investors. The breadth of the investor base—spanning strategic corporate investors, institutional venture capital, and community-focused funds—suggests multi-stakeholder confidence in the company's technology trajectory and market potential.
The funding structure underscores activity in the Pacific Northwest's medtech venture ecosystem, with participation from regional players alongside nationally-recognized early-stage investors. For hedge funds and institutional investors tracking medtech innovation in automation and robotic systems, Dopl's capital raise represents a representative data point in the ongoing consolidation of venture capital around clinical automation and diagnostic workflow optimization.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.